Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-04 KREHER NERISSA Chief Medical Officer Option exercise 10b5-1 +6,898 $2.10 $14K 34,028
2023-08-04 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −6,898 $14.14 $98K 27,130
2023-08-04 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −6,898 88,012
2023-08-03 KREHER NERISSA Chief Medical Officer Option exercise 10b5-1 +9,464 $2.10 $20K 36,594
2023-08-03 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −9,464 $14.74 $140K 27,130
2023-08-03 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −9,464 94,910
2023-08-02 KREHER NERISSA Chief Medical Officer Option exercise 10b5-1 +10,348 $2.10 $22K 37,478
2023-08-02 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −9,280 $15.09 $140K 28,198
2023-08-02 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −1,000 $16.01 $16K 27,198
2023-08-02 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −68 $16.82 $1K 27,130
2023-08-02 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −10,348 104,374
2023-07-11 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +3,884 $2.10 $8K 40,631
2023-07-11 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −3,884 $18.00 $70K 36,747
2023-07-11 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −3,884 64,657
2023-07-11 Dowden Nathan J Chief Operating Officer Sale 10b5-1 −3,897 $18.05 $70K 35,376
2023-07-11 Sethuraman Natarajan Chief Scientific Officer Sale 10b5-1 −14,852 $18.04 $268K 153,447
2023-07-10 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +6,116 $2.10 $13K 42,863
2023-07-10 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −6,116 $17.98 $110K 36,747
2023-07-10 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −6,116 68,541
2023-07-10 Dowden Nathan J Chief Operating Officer Sale 10b5-1 −3,200 $18.00 $58K 39,273

Page 15 of 26 · 517 trades